Follow
Claude C Bernard
Claude C Bernard
Emeritus Professor, Australian Regenerative Medicine Institute, Monash University, Melbourne
Verified email at monash.edu
Title
Cited by
Cited by
Year
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas, SE Baranzini, D Mitchell, CCA Bernard, SR Rittling, ...
Science 294 (5547), 1731-1735, 2001
10802001
IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis.
DO Willenborg, S Fordham, CC Bernard, WB Cowden, IA Ramshaw
Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3223-3227, 1996
7641996
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
J Liu, MW Marino, G Wong, D Grail, A Dunn, J Bettadapura, AJ Slavin, ...
Nature medicine 4 (1), 78-83, 1998
6901998
High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial
F Stéphan, B Barrucand, P Petit, S Rézaiguia-Delclaux, A Médard, ...
Jama 313 (23), 2331-2339, 2015
5772015
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis
V Brundula, NB Rewcastle, LM Metz, CC Bernard, VW Yong
Brain 125 (6), 1297-1308, 2002
5452002
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis
JL McQualter, R Darwiche, C Ewing, M Onuki, TW Kay, JA Hamilton, ...
The Journal of experimental medicine 194 (7), 873-882, 2001
5232001
Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients
JR Oksenberg, S Stuart, AB Begovich, RB Bell, HA Erlich, L Steinman, ...
Nature 345 (6273), 344-346, 1990
5131990
Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis
JR Oksenberg, MA Panzara, AB Begovich, D Mitchell, HA Erlich, ...
Nature 362 (6415), 68-70, 1993
5061993
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
C Charlier, É Perrodeau, A Leclercq, B Cazenave, B Pilmis, B Henry, ...
The Lancet Infectious Diseases 17 (5), 510-519, 2017
4702017
MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
N Molnarfi, U Schulze-Topphoff, MS Weber, JC Patarroyo, T Prod’homme, ...
Journal of Experimental Medicine 210 (13), 2921-2937, 2013
4362013
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
A Hartemann, G Bensimon, CA Payan, S Jacqueminet, O Bourron, ...
The lancet Diabetes & endocrinology 1 (4), 295-305, 2013
4322013
Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
NK De Rosbo, R Milo, MB Lees, D Burger, CC Bernard, A Ben-Nun
The Journal of clinical investigation 92 (6), 2602-2608, 1993
4151993
B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions
SE Baranzini, MC Jeong, C Butunoi, RS Murray, CCA Bernard, ...
The Journal of Immunology 163 (9), 5133-5144, 1999
3631999
Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis
CCA Bernard, TG Johns, A Slavin, M Ichikawa, C Ewing, J Liu, ...
Journal of molecular medicine 75, 77-88, 1997
3611997
The structure and function of myelin oligodendrocyte glycoprotein
TG Johns, CCA Bernard
Journal of neurochemistry 72 (1), 1-9, 1999
3421999
Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy
L Steinman, R Martin, C Bernard, P Conlon, JR Oksenberg
Annual review of neuroscience 25 (1), 491-505, 2002
3342002
Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
M Rosenzwajg, R Lorenzon, P Cacoub, HP Pham, F Pitoiset, K El Soufi, ...
Annals of the rheumatic diseases 78 (2), 209-217, 2019
3282019
B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity
MS Weber, T Prod'Homme, JC Patarroyo, N Molnarfi, T Karnezis, ...
Annals of neurology 68 (3), 369-383, 2010
3272010
The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
T Karnezis, W Mandemakers, JL McQualter, B Zheng, PP Ho, KA Jordan, ...
Nature neuroscience 7 (7), 736-744, 2004
3132004
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
WH Robinson, P Fontoura, BJ Lee, HEN De Vegvar, J Tom, R Pedotti, ...
Nature biotechnology 21 (9), 1033-1039, 2003
2942003
The system can't perform the operation now. Try again later.
Articles 1–20